Human Langerhans Cells Control Th Cells via Programmed Death-Ligand 1 in Response to Bacterial Stimuli and Nickel-Induced Contact Allergy

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Hitzler, Manuel ^a   Majdic, Otto ^b   Heine, Guido ^c   Worm, Margitta ^c   Ebert, Grit ^d   Luch, Andreas ^a   Peiser, Matthias ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 22; NICKEL; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIUM; CD4+ T LYMPHOCYTE; CELL STIMULATION; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE RELEASE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LANGERHANS CELL; MEMORY T LYMPHOCYTE; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SKIN ALLERGY; STIMULUS RESPONSE; UPREGULATION;

BACTERIAL INFECTIONS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYTOKINES; DERMATITIS, ALLERGIC CONTACT; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; LANGERHANS CELLS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; NICKEL; PROGRAMMED CELL DEATH 1 RECEPTOR; T-LYMPHOCYTES, HELPER-INDUCER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84867298675     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046776     Document Type: Article

References (40)

1. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL, (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-2357.
2. Murphy KM, Reiner SL, (2002) The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
3. Zhu J, Yamane H, Paul WE, (2010) Differentiation of effector CD4 T cell populations (*). Annu Rev Immunol 28: 445-489.
4. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F, (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
5. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H, (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871.
6. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, et al. (2008) Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
7. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, et al. (2008) IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281.
8. Khader SA, Bell GK, Pearl JE, Fountain JJ, Rangel-Moreno J, et al. (2007) IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8: 369-377.
9. Higgins SC, Jarnicki AG, Lavelle EC, Mills KH, (2006) TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J Immunol 177: 7980-7989.
10. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585.
11. Larsen JM, Bonefeld CM, Poulsen SS, Geisler C, Skov L, (2009) IL-23 and T(H)17-mediated inflammation in human allergic contact dermatitis. J Allergy Clin Immunol 123: 486-492.
12. Nestle FO, Di MP, Qin JZ, Nickoloff BJ, (2009) Skin immune sentinels in health and disease. Nat Rev Immunol 9: 679-691.
13. Schmidt M, Raghavan B, Muller V, Vogl T, Fejer G, et al. (2010) Crucial role for human Toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol 11: 814-819.
14. Kim YS, Choi SJ, Tae YM, Lee BJ, Jeon SG, et al. (2010) Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide-containing allergens in the lung. J Immunol 185: 5648-5655.
15. Keir ME, Butte MJ, Freeman GJ, Sharpe AH, (2008) PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 26: 677-704.
16. Francisco LM, Sage PT, Sharpe AH, (2010) The PD-1 pathway in tolerance and autoimmunity. Immunol Rev 236: 219-242.
17. Selenko-Gebauer N, Majdic O, Szekeres A, Hofler G, Guthann E, et al. (2003) B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy. J Immunol 170: 3637-3644.
18. Fife BT, Bluestone JA, (2008) Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways. Immunol Rev 224: 166-182.
19. Riley JL, (2009) PD-1 signaling in primary T cells. Immunol Rev 229: 114-125.
20. Geissmann F, Dieu-Nosjean MC, Dezutter C, Valladeau J, Kayal S, et al. (2002) Accumulation of immature Langerhans cells in human lymph nodes draining chronically inflamed skin. J Exp Med 196: 417-430.
21. Peiser M, Grutzkau A, Wanner R, Kolde G, (2003) CD1a and CD1c cell sorting yields a homogeneous population of immature human Langerhans cells. J Immunol Methods 279: 41-53.
22. Reiser H, Schneeberger EE (1996) Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur J Immunol 26: 880-885. 10.1002/eji.1830260424 [doi].
23. Katayama I, Matsunaga T, Yokozeki H, Nishioka K, (1997) Blockade of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) down-regulates induction of contact sensitivity by haptenated epidermal cells. Br J Dermatol 136: 846-852.
24. Tang A, Judge TA, Turka LA, (1997) Blockade of CD40-CD40 ligand pathway induces tolerance in murine contact hypersensitivity. Eur J Immunol 27: 3143-3150.
25. Trompette A, Divanovic S, Visintin A, Blanchard C, Hegde RS, et al. (2009) Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein. Nature 457: 585-588.
26. Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, et al. (2007) Phenotypic and functional features of human Th17 cells. J Exp Med 204: 1849-1861.
27. Pena-Cruz V, McDonough SM, Diaz-Griffero F, Crum CP, Carrasco RD, et al. (2010) PD-1 on immature and PD-1 ligands on migratory human Langerhans cells regulate antigen-presenting cell activity. J Invest Dermatol 130: 2222-2230.
28. Brown JA, Dorfman DM, Ma FR, Sullivan EL, Munoz O, et al. (2003) Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production. J Immunol 170: 1257-1266.
29. Aiba S, Katz SI, (1990) Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 145: 2791-2796.
30. Aiba S, Terunuma A, Manome H, Tagami H, (1997) Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules. Eur J Immunol 27: 3031-3038.
31. McAleer JP, Vella AT, (2010) Educating CD4 T cells with vaccine adjuvants: lessons from lipopolysaccharide. Trends Immunol 31: 429-435.
32. Tsushima F, Iwai H, Otsuki N, Abe M, Hirose S, et al. (2003) Preferential contribution of B7-H1 to programmed death-1-mediated regulation of hapten-specific allergic inflammatory responses. Eur J Immunol 33: 2773-2782.
33. Kim HK, Guan H, Zu G, Li H, Wu L, et al. (2006) High-level expression of B7-H1 molecules by dendritic cells suppresses the function of activated T cells and desensitizes allergen-primed animals. J Leukoc Biol 79: 686-695.
34. Milovanovic M, Drozdenko G, Weise C, Babina M, Worm M, (2010) Interleukin-17A promotes IgE production in human B cells. J Invest Dermatol 130: 2621-2628.
35. Kaplan DH, Kissenpfennig A, Clausen BE, (2008) Insights into Langerhans cell function from Langerhans cell ablation models. Eur J Immunol 38: 2369-2376.
36. Kaplan DH, Jenison MC, Saeland S, Shlomchik WD, Shlomchik MJ, (2005) Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23: 611-620.
37. Bennett CL, van RE, Jung S, Inaba K, Steinman RM, et al. (2005) Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169: 569-576.
38. Kissenpfennig A, Henri S, Dubois B, Laplace-Builhe C, Perrin P, et al. (2005) Dynamics and function of Langerhans cells in vivo: dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22: 643-654.
39. Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, et al. (2000) Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood 96: 2808-2813.
40. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T, (1995) Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol 155: 4207-4217.